They are always light on news unless it is sensitive to be honest. They are making a habit of missing timelines so this is surely all priced in now, all we can actually go off is Theo r timelines.. CR, sure there is one coming. Qn is can they rip out a material trial update before hand and re rate or not. Good news on that TBI trial could see them at a 50m mkt cap, 100m mkt cap??. I can’t help but think they should have been focusing on the TBI and not so much the cholesterol, despite it also being a big opportunity… if they can get some good trial results on cholesterol though I’d still be happy to see them take a partnering deal, it solves the CR issue, timing may limit that strategy. Generally, biotechs are very unloved at the moment. If the market gets any whiff that you need to raise in the next 2 years it has been hammered. NYR is caught up in that. I wish I had only entered at 9c! Good luck.
NYR Price at posting:
8.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)